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Abstract
Mirizzi syndrome is a rare condition caused by the obstruction of the common bile duct or common hepatic duct by
external compression from multiple impacted gallstones or a single large impacted gallstone in Hartman's pouch. The
condition can easily be confused with choledocholithiasis, bile duct stricture or cholangiocarcinoma due to the presence
of obstructive jaundice hence may be overlooked due to the rarity of the condition. The incidence of Mirizzi syndrome
among patients with gallstones is reported to range from 0.63 to 5.7%. Furthermore, it poses a differential diagnosis
dilemma for the physician as well as radiologists because there are no clinical features or diagnostic procedures that have
a 100% speciﬁcity and sensitivity. Laparotomy is the preferred surgical technique of choice. For the patients who are poor
surgical candidate, mainstay of treatment is biliary stent placement for the restoration of normal biliary drainage. Due to
low incidence of the Mirizzi syndrome, an elevated index of suspicion is required to diagnose this condition. At present,
there are no well-developed, internationally recognized clinical guidelines for the management of this syndrome.
Furthermore, the diagnostic procedures available still pose a barrier in the ability to conﬁrm the diagnosis prior to
surgical treatment, even though the diagnostic rate has increased dramatically.

1. Introduction

M

irizzi syndrome is a rare complication of
chronic cholelithiasis within the neck or
infundibulum of the gallbladder or cystic duct that
causes extrinsic compression of the common bile
duct (CBD) or common hepatic duct (CHD). The
typical presentation is RUQ abdominal pain, jaundice, and fever. Management includes endoscopic
retrograde cholangiopancreatography (ERCP) for
biliary decompression followed by laparoscopic
cholecystectomy or an open approach depending
on the classiﬁcation. We presented an 83-year-old
male with a past medical history of seizure disorder
and contracture found to have Mirizzi syndrome
that was successfully managed by percutaneous
trans-hepatic biliary drainage. ERCP and cholecystectomy could not be performed due to the patient's unfavorable gastrointestinal tract anatomy
and poor surgical candidate status, respectively
(see Fig. 1).

2. Case presentation
83-year-old male with a past medical history of
seizure disorder resulting in contractures, presented
to the hospital after being found to have elevated
liver enzymes during a routine laboratory test performed at the nursing home. On presentation, the
patient was asymptomatic, afebrile, and hemodynamically stable. On physical examination, he was
jaundiced with icteric sclera. Pertinent labs include
normal white blood cells, aspartate aminotransferase 77 U/L, alanine aminotransferase 91 U/L,
alkaline phosphatase 430 U/L, total bilirubin 8 mg/
dL direct bilirubin 5 mg/dL and an INR of 1. Right
upper quadrant ultrasound was remarkable for a
large gallstone with a contracted gallbladder and
intrahepatic biliary dilatation. Abdominal CT with
contrast revealed a 12 mm gallstone at the gallbladder neck with a contracted gallbladder, causing
extrinsic compression of the common hepatic duct
(CHD) with moderate intrahepatic bile duct
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Fig. 1. Fluoroscopic image illustrating common hepatic duct obstruction and narrowing by external compression from gallbladder. PTC (Percutaneous
transhepatic cholangiography) tube, CHD (common hepatic duct), CBD (common bile duct), CD (cystic duct).

dilatation, suspicious for MS. An ERCP was
attempted with the hope of retrieving the gallstone.
Attributed to his unfavorable gastrointestinal tract
anatomy, the ampulla could not be localized, and
the CHD could not be cannulated. Pre-operational
evaluation for possible cholecystectomy concluded
that the patient was a poor surgical candidate due to
age and the contractures. Hence, he underwent
percutaneous transhepatic cholangiogram which
conﬁrmed the diagnosis of MS, as the large gallstone caused a mass effect on the common hepatic
duct. Internal/external biliary drainage catheter was
placed by interventional radiology which was
eventually replaced by a metallic stent placed across
the narrowed portion of CHD, after which his
elevated liver enzymes down trended. He was discharged back to the nursing home.

3. Discussion
Mirizzi syndrome is a product of chronic cholelithiasis, where the impaction of a single or multiple
stones within the neck or infundibulum (Hartmann's pouch) of the gallbladder or cystic duct
produces extrinsic compression of other biliary
structures such as the common hepatic and common bile duct. Over time, inﬂammation and biliary

stasis due to obstruction cause erosion of the gallbladder and cystic duct walls, which may lead to the
formation
of
cholecystohepatic
or
cholecystocholedochal ﬁstulas. In rare cases, some may
present with cholecystoenteric ﬁstulas.1 Even
though the most widely used classiﬁcation system in
literature (Csendes) categorizes compression of the
common bile duct as a type I form of Mirizzi syndrome, the incidence of the condition is rare,
occurring in only 1e4% of patients undergoing
cholecystectomy, and in 0.05e4% of patients undergoing surgery for cholelithiasis.2
Common clinical manifestations of the disease
include right upper quadrant pain, signs of
obstructive jaundice, and acute cholangitis.1,3,4 All
three symptoms however are only present in about
44e71% of patients.4 Other symptoms included
nausea, vomiting, and anorexia.3,5 One study reported that 50% of patients exhibited a positive
Murphy's sign.3 They can also present with acute
cholecystitis, pancreatitis, and choledocholithiasis.5
Between 3.7 and 17% of patients are asymptomatic.3 Diagnostic ﬁndings are non-sensitive and
non-speciﬁc, and a high index of suspicion is
needed when arriving at a diagnosis. Elevated
bilirubin and alkaline phosphatase are the most
common ﬁndings, seen in more than 90% of

patients. Leukocytosis is seen in patients with
accompanying cholangitis or cholecystitis. Other
ﬁndings include elevated liver function enzymes
and gamma glutamyl transferase. There has been a
substantial association between Mirizzi syndrome
and gallbladder carcinoma, with an incidence
among patients with Mirizzi syndrome as high as
28%.1,6 Few case reports have also shown elevated
CA19-9 in the absence of malignancy. Imaging is
almost always needed to arrive at a preoperative
diagnosis.1,5
The gold standard for diagnosis is ERCP with a
sensitivity ranging from 76 to 100%.7 It offers the best
visualization of the extra-hepatic bile ducts and can
show compression by impacted gallstones in the
common bile duct with resulting proximal biliary
dilatation as was the case in our patient. Furthermore, ERCP can accurately determine the presence
of ﬁstulas. Therapeutic options such as stenting,
nasobiliary drainage, or stone removal may also be
performed during the procedure, helping to relieve
obstruction preoperatively.8 One study has demonstrated that pre-op stenting also aids in identifying
the common bile duct during surgery in patients
with abnormal Triangle of Calot and biliary tree
anatomy.3 Complications may arise from ERCP
which include infection and (1.4%) and perforation
(0.6%).9 Other common modalities include ultrasound, CT, and MRCP. Abdominal ultrasound may
demonstrate dilation above the level of the gallbladder neck with the presence of an impacted stone,
accompanied by changes to the width of the common
bile duct. Current literature reports a diagnostic accuracy of 29%, with a sensitivity between 8.3% and
27%. Some studies have shown sensitivities as high
as 72%. Ultrasound however is unable to distinguish
whether the cause of bile duct narrowing is due to
metastatic invasion or gallstone compression.7 The
sensitivity and speciﬁcity of abdominal CT scans vary
widely between 42 and 99%. Its ability to distinguish
Mirizzi syndrome from hepatic inﬁltration of metastatic tumors, particularly in patients with ﬁstulas, is
a major strength. Lastly, MRCP demonstrates sensitivity across studies at about 50%, however, it is
limited due to its inefﬁciency in localizing ﬁstulas.7 If
ERCP is not an option, using multiple imaging modalities can greatly increase the chance of preoperative diagnosis. One study showed that MRCP
combined with CT yielded a diagnostic accuracy as
high as 98% vs. 84% for CT alone.10
At present, Mirizzi syndrome is managed without
well-developed, internationally recognized clinical
guidelines. Furthermore, advancement in diagnostic
techniques has not made it easier for a conﬁrmed
diagnosis to be made before surgery, even though
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diagnostic rates have improved markedly.7 Laparotomy is usually chosen as the mode of treatment.
This usually involves total or partial cholecystectomy of the fundus and neck with repair of
compromised biliary structures.1,5,7 Due to the association with gallbladder carcinoma, all excised
tissue should undergo pathologic examination to
rule out unsuspected carcinoma. The insertion of a
T-tube or nasobiliary decompression is usually done
pre and postoperatively to prevent further biliary
leaks, strictures, or the development of cholangitis.5
While the laparoscopic approach was avoided in the
past due to high variability in the hepatobiliary
anatomy seen in these patients leading to bile duct
injury and high rates of conversion to open laparotomy, newer evidence suggests that the laparoscopic approach after ERCP identiﬁcation and
therapeutic management is a reliable option in patients with a pre-operative diagnosis.7,8,11
For patients who are poor medical candidates for
surgery, treatment presents a medical conundrum
that revolves around alleviating the acute symptoms
at presentation and maintaining long-term patency
hepatobiliary tree. For patients with type I Mirizzi
syndrome, such treatment involves therapeutic
ERCP for sphincterotomy and stone extraction via
basket or balloon, dissolution therapy, or lithotripsy.12 Percutaneous stone removal is usually
reserved for patients who have failed endoscopic
access and who are unsuitable surgical candidates.
Stone removal tends to provide signiﬁcant relief and
is usually done after decompression via biliary
drainage either from transhepatic percutaneous
drainage or endoscopic nasobiliary tube.8,12,13
Coupled with antibiotic therapy and decompression, endoscopic therapies can resolve initial presenting symptoms of cholangitis and obstructive
jaundice. While the removal of impacted stones is
desirable in non-surgical endoscopic therapy, there
are cases where complete stone removal cannot be
achieved, either due to anatomical issues or to the
stone being impacted above the cystic duct, such as
in Hartmann's pouch. In these cases, biliary stenting
may provide a long-term option for relief.12,13 One
case report where the authors used a biliary stent in
an elderly patient whose stone was left in situ
demonstrated no complications at 2e5 years followup.14 In a 2006 study, 6 patients who were determined to be poor surgical candidates underwent
deﬁnitive endoscopic treatment. Outcomes showed
low post-procedure morbidity, with only one patient
dying due to stent migration leading to duodenal
perforation. The rest of the patients were doing well
upon follow-up which ranged from 1 to 7 months.13
The most common complication of endoscopic
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biliary stenting as a long-term option is recurrent
cholangitis. Due to the risk of complications that
may occur post-procedure, the use of endoscopic
therapies as the deﬁnitive treatment for patients
with Type I Mirizzi syndrome should be reserved
for patients with severe comorbidities, poor surgical
candidates, or short life expectancies.12 These patients should also be followed up closely to monitor
for any complications that may arise, with stents
being evaluated and replaced as needed to maintain
adequate biliary patency. Nevertheless, this treatment option allows for successful medical management in patients deemed poor candidates for
surgery and may be used in this population as a
potential long-term solution.

4. Conclusion
Gallstones are a prevalent medical condition that
might result in long-term complications like Mirizzi
syndrome. Given that the clinical and biochemical
manifestations of MS resemble other medical disorders, establishing pre-operative diagnosis requires a high index of suspicion. This syndrome can
be managed by percutaneous trans-hepatic biliary
drainage when surgical intervention and ERCP are
deemed to be unfeasible. Although such management carries risks of re-obstruction and/or infection,
relieving the obstruction in the acute settings in
such patient is deemed necessary to prevent
morbidity or mortality.
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